title: [Two classes of medicine: what are the consequences of treatment advances with new recombinant proteins?].
authors.forename: Theodor
authors.initials: T
authors.lastname: Dingermann
authors.forename: Manfred
authors.initials: M
authors.lastname: Schubert-Zsilavecz
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001709:Biotechnology; D010600:Pharmacology / Q000639:trends*; D011994:Recombinant Proteins / Q000627:therapeutic use*
chemical_list: D018501:Antirheumatic Agents; D011994:Recombinant Proteins